Dube Eric M (CIK 1763494) reported 26 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-04-15). Recent activity: Buy TVTX (64,000 shares), Sell TVTX (56,815 shares), Sell TVTX (7,165 shares), Sell TVTX (20 shares), Buy TVTX (60,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-15 | Travere Therapeutics, Inc. (TVTX) | CHIEF EXECUTIVE OFFICER | Buy | 64,000 | $0 |
| 2026-04-15 | Travere Therapeutics, Inc. (TVTX) | CHIEF EXECUTIVE OFFICER | Sell | 56,815 | $2.3M |
| 2026-04-15 | Travere Therapeutics, Inc. (TVTX) | CHIEF EXECUTIVE OFFICER | Sell | 7,165 | $299,139 |
| 2026-04-15 | Travere Therapeutics, Inc. (TVTX) | CHIEF EXECUTIVE OFFICER | Sell | 20 | $853 |
| 2026-04-02 | Travere Therapeutics, Inc. (TVTX) | CHIEF EXECUTIVE OFFICER | Buy | 60,000 | $927,600 |
| 2026-04-02 | Travere Therapeutics, Inc. (TVTX) | CHIEF EXECUTIVE OFFICER | Sell | 34,902 | $1.1M |
| 2026-04-02 | Travere Therapeutics, Inc. (TVTX) | CHIEF EXECUTIVE OFFICER | Sell | 25,098 | $789,583 |
| 2026-02-24 | Travere Therapeutics, Inc. (TVTX) | CHIEF EXECUTIVE OFFICER | Buy | 60,000 | $927,600 |
| 2026-02-24 | Travere Therapeutics, Inc. (TVTX) | CHIEF EXECUTIVE OFFICER | Sell | 60,000 | $1.8M |
| 2026-02-03 | Travere Therapeutics, Inc. (TVTX) | CHIEF EXECUTIVE OFFICER | Buy | 113,800 | $0 |
| 2026-02-03 | Travere Therapeutics, Inc. (TVTX) | CHIEF EXECUTIVE OFFICER | Sell | 66,452 | $2.1M |
| 2026-02-03 | Travere Therapeutics, Inc. (TVTX) | CHIEF EXECUTIVE OFFICER | Sell | 33,635 | $1.1M |
| 2026-01-27 | Travere Therapeutics, Inc. (TVTX) | CHIEF EXECUTIVE OFFICER | Buy | 8,135 | $125,767 |
| 2026-01-27 | Travere Therapeutics, Inc. (TVTX) | CHIEF EXECUTIVE OFFICER | Sell | 8,135 | $244,131 |
| 2026-01-27 | Travere Therapeutics, Inc. (TVTX) | CHIEF EXECUTIVE OFFICER | Buy | 51,865 | $801,833 |
| 2026-01-27 | Travere Therapeutics, Inc. (TVTX) | CHIEF EXECUTIVE OFFICER | Sell | 51,865 | $1.6M |
| 2025-10-30 | Travere Therapeutics, Inc. (TVTX) | CHIEF EXECUTIVE OFFICER | Buy | 92,872 | $1.4M |
| 2025-10-30 | Travere Therapeutics, Inc. (TVTX) | CHIEF EXECUTIVE OFFICER | Sell | 92,872 | $2.8M |
| 2025-10-30 | Travere Therapeutics, Inc. (TVTX) | CHIEF EXECUTIVE OFFICER | Buy | 27,128 | $419,399 |
| 2025-10-30 | Travere Therapeutics, Inc. (TVTX) | CHIEF EXECUTIVE OFFICER | Sell | 27,128 | $817,095 |
| 2025-05-05 | Travere Therapeutics, Inc. (TVTX) | CHIEF EXECUTIVE OFFICER | Buy | 18,924 | $0 |
| 2025-05-05 | Travere Therapeutics, Inc. (TVTX) | CHIEF EXECUTIVE OFFICER | Sell | 18,924 | $398,350 |
| 2025-02-12 | Travere Therapeutics, Inc. (TVTX) | CHIEF EXECUTIVE OFFICER | Sell | 11,375 | $273,455 |
| 2025-02-04 | Travere Therapeutics, Inc. (TVTX) | CHIEF EXECUTIVE OFFICER | Buy | 130,000 | $0 |
| 2025-02-04 | Travere Therapeutics, Inc. (TVTX) | CHIEF EXECUTIVE OFFICER | Sell | 50,691 | $1.0M |
Source: SEC Form 4 filings · as of 2026-04-15